Trials / Withdrawn
WithdrawnNCT03286205
A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sutter Gould Medical Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.
Detailed description
The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia. The two dosing regimens under review are a low dose weekly or a larger dose given every three weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IV iron | IV iron infusion based on weekly or every 3 week dosage. |
Timeline
- Start date
- 2015-04-14
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
- First posted
- 2017-09-18
- Last updated
- 2019-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03286205. Inclusion in this directory is not an endorsement.